Octreotide scintigraphy. A new method for diagnosing pancreatic tumors.
AUTOR(ES)
Merrell
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1235330Documentos Relacionados
- Preoperative localization of gastrointestinal endocrine tumors using somatostatin-receptor scintigraphy.
- The use of somatostatin receptor scintigraphy in the differential diagnosis of pancreatic duct cancers and islet cell tumors.
- Vasodilator and exercise cardiac perfusion scintigraphy.
- 68Ga-DOTATATE PET/CT versus 111In-octreotide scintigraphy in patients with neuroendocrine tumors: a prospective study
- Ultrafast magnetic resonance imaging improves the staging of pancreatic tumors.